A detailed history of Versor Investments LP transactions in Biolife Solutions Inc stock. As of the latest transaction made, Versor Investments LP holds 15,363 shares of BLFS stock, worth $426,015. This represents 0.06% of its overall portfolio holdings.

Number of Shares
15,363
Previous 18,600 17.4%
Holding current value
$426,015
Previous $424,000 22.17%
% of portfolio
0.06%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025

SELL
$20.64 - $25.27 $66,811 - $81,798
-3,237 Reduced 17.4%
15,363 $330,000
Q1 2025

May 13, 2025

BUY
$22.84 - $28.49 $424,824 - $529,914
18,600 New
18,600 $424,000
Q2 2022

Jul 27, 2022

BUY
$10.54 - $24.2 $111,723 - $256,520
10,600 Added 67.52%
26,300 $363,000
Q1 2022

May 04, 2022

BUY
$20.81 - $37.29 $326,717 - $585,453
15,700 New
15,700 $357,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.18B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Versor Investments LP Portfolio

Follow Versor Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.